Letter: “High Rates of Unnecessary Surgery for Indeterminate Thyroid Nodules in the Absence of Molecular Test and the Cost-Effectiveness of Utilizing Molecular Test in an Asian Population: A Decision Analysis” by Fung et al
Restricted accessLetterFirst published online May, 2025
Letter: “High Rates of Unnecessary Surgery for Indeterminate Thyroid Nodules in the Absence of Molecular Test and the Cost-Effectiveness of Utilizing Molecular Test in an Asian Population: A Decision Analysis” by Fung et al
FungMHM, TangC, KwokGW, et al.High rates of unnecessary surgery for indeterminate thyroid nodules in the absence of molecular test and the cost-effectiveness of utilizing molecular test in an asian population: A decision analysis. Thyroid, 2025; 35(2):166–176; doi: 10.1089/thy.2024.0436
2.
KhanTM, ZeigerMA. Thyroid nodule molecular testing: Is it ready for prime time? Front Endocrinol (Lausanne), 2020; 11:590128; doi: 10.3389/fendo.2020.590128
3.
NgoHTT, NguyenTPX, VuTH, et al.Impact of molecular testing on the management of indeterminate thyroid nodules among Western and Asian countries: A systematic review and meta-analysis. Endocr Pathol, 2021; 32(2):269–279; doi: 10.1007/s12022-020-09643-0
4.
KakudoK, JungCK, LiuZ, et al.The Asian Thyroid Working Group, from 2017 to 2023. J Pathol Transl Med, 2023; 57(6):289–304; doi: 10.4132/jptm.2023.10.04
5.
KakudoK, HiguchiM, HirokawaM, et al.Thyroid FNA cytology in Asian practice-Active surveillance for indeterminate thyroid nodules reduces overtreatment of thyroid carcinomas. Cytopathology, 2017; 28(6):455–466; doi: 10.1111/cyt.12491
